InvestorsHub Logo
Followers 35
Posts 1202
Boards Moderated 1
Alias Born 08/27/2000

Re: Bio7mm post# 3571

Saturday, 09/06/2014 1:59:39 PM

Saturday, September 06, 2014 1:59:39 PM

Post# of 34770

My confidence in TapImmune's approach lies in the fact that Knutson's new her2 neu epitopes licensed to TapImmune in April 2012 are naturally processed in the proteasome as opposed to the Galena epitope which is not naturally processed. I am not a scientist but this is what I have learned through extensive research watching all the YouTube videos of Knutson and Glynn Wilson and reading all the info I could find.



You're correct about NPE's, and their ability to naturally modulate TAP.

I'll be posting here, as this is in my immunotherapeutic wheelhouse, and the mono-therapeutic potential is intriguing..

All the best,
John


Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News